首页> 美国卫生研究院文献>Pharmaceutics >Semi-solid Sucrose Stearate-Based Emulsions as Dermal Drug Delivery Systems
【2h】

Semi-solid Sucrose Stearate-Based Emulsions as Dermal Drug Delivery Systems

机译:半固态蔗糖硬脂酸酯基乳液作为皮肤药物输送系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mild non-ionic sucrose ester surfactants can be employed to produce lipid-based drug delivery systems for dermal application. Moreover, sucrose esters of intermediate lipophilicity such as sucrose stearate S-970 possess a peculiar rheological behavior which can be employed to create highly viscous semi-solid formulations without any further additives. Interestingly, it was possible to develop both viscous macroemulsions and fluid nanoemulsions with the same chemical composition merely by slight alteration of the production process. Optical light microscopy and cryo transmission electron microscopy (TEM) revealed that the sucrose ester led to the formation of an astonishing hydrophilic network at a concentration of only 5% w/w in the macroemulsion system. A small number of more finely structured aggregates composed of surplus surfactant were likewise detected in the nanoemulsions. These discoveries offer interesting possibilities to adapt the low viscosity of fluid O/W nanoemulsions for a more convenient application. Moreover, a simple and rapid production method for skin-friendly creamy O/W emulsions with excellent visual long-term stability is presented. It could be shown by franz-cell diffusion studies and in vitro tape stripping that the microviscosity within the semi-solid formulations was apparently not influenced by their increased macroviscosity: the release of three model drugs was not impaired by the complex network-like internal structure of the macroemulsions. These results indicate that the developed semi-solid emulsions with advantageous application properties are highly suitable for the unhindered delivery of lipophilic drugs despite their comparatively large particle size and high viscosity.
机译:温和的非离子型蔗糖酯表面活性剂可用于生产用于皮肤的脂质基药物递送系统。此外,具有中等亲脂性的蔗糖酯,例如硬脂酸蔗糖S-970,具有独特的流变行为,可用于制备高粘度的半固体制剂,而无需任何其他添加剂。有趣的是,仅通过稍微改变生产过程就可以开发具有相同化学组成的粘性大乳液和流体纳米乳液。光学显微镜和低温透射电子显微镜(TEM)显示,在大乳液体系中,蔗糖酯仅以5%w / w的浓度形成了惊人的亲水网络。在纳米乳液中同样检测到少量由剩余表面活性剂组成的更精细结构的聚集体。这些发现提供了有趣的可能性,以适应流体O / W纳米乳液的低粘度,以便更方便地应用。此外,提出了一种简单且快速的皮肤友好型乳状O / W乳液的生产方法,该乳液具有优异的视觉长期稳定性。通过弗朗兹细胞扩散研究和体外胶带剥离法可以表明,半固体制剂中的微粘度显然不受其增加的大粘度影响:三种模型药物的释放不受复杂的网络状内部结构的损害大乳液。这些结果表明,尽管具有相对较大的粒径和高粘度,但具有有利的应用性能的已开发的半固体乳液非常适合无阻递送亲脂性药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号